MEGAN C ALLMAN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health WEST COLUMBIA, SC NPI 1780163709
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health SC NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$2,086.25
- Category: General Payments
- Program years: PY2022–2024
- Record count: 98
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,426.83 across 67 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,326.84 | 66 |
| Education | $99.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $155.11 | 7 |
| Celgene Corporation | $136.35 | 7 |
| PFIZER INC. | $133.56 | 8 |
| Merck Sharp & Dohme Corporation | $123.68 | 5 |
| Astellas Pharma US Inc | $118.38 | 2 |
| Daiichi Sankyo Inc. | $97.59 | 4 |
| Incyte Corporation | $79.54 | 4 |
| Regeneron Healthcare Solutions, Inc. | $64.99 | 3 |
| ABBVIE INC. | $63.32 | 3 |
| Janssen Biotech, Inc. | $59.97 | 3 |
| E.R. Squibb & Sons, L.L.C. | $48.36 | 3 |
| Lilly USA, LLC | $45.21 | 2 |
| Genentech USA, Inc. | $34.84 | 2 |
| Acerta Pharma LLC | $30.76 | 2 |
| Gilead Sciences, Inc. | $28.19 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.45 | 1 |
| Ipsen Biopharmaceuticals, Inc | $22.60 | 1 |
| Adaptive Biotechnologies Corporation | $21.73 | 1 |
| GlaxoSmithKline, LLC. | $21.57 | 1 |
| Karyopharm Therapeutics Inc. | $19.99 | 1 |
| Rigel Pharmaceuticals, Inc. | $18.97 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.51 | 1 |
| SOBI, INC | $15.54 | 1 |
| Mirati Therapeutics, Inc. | $14.13 | 1 |
| ARRAY BIOPHARMA INC | $13.88 | 1 |
| SpringWorks Therapeutics, Inc. | $13.61 | 1 |
By program year
Records — PY2024 (67)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.